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The Saccharomyces cerevisiae ras-like gene RSR1 is particularly closely related to the mammalian gene
Krev-1 (also known as smg2lA and raplA). RSRI was originally isolated as a multicopy suppressor of a cdc24
mutation, which causes an inability to bud or establish cell polarity. Deletion of RSR1 itself does not affect
growth but causes a randomization of bud position. We have now constructed mutant alleles ofRSRI encoding
proteins with substitutions of Val for Gly at position 12 (analogous to constitutively activated Ras proteins) or
Asn for Lys at position 16 (analogous to a dominant-negative Ras protein). rsrlvaIl2 could not restore a normal
budding pattern to an rsrl deletion strain but could suppress a cdc24 mutation when overexpressed. rsrlAsn l6
could randomize the budding pattern of a wild-type strain even in low copy number but was not lethal even in
high copy number. These and other results suggest that Rsrlp functions only in bud site selection and not in
subsequent events of polarity establishment and bud formation, that this function involves a cycling between
GTP-bound and GDP-bound forms of the protein, and that the suppression of cdc24 involves direct interaction
between Rsrlp[GTP] and Cdc24p. Functional homology between Rsrlp and Krev-1 p21 was suggested by the
observations that expression of the latter protein in yeast cells could both suppress a cdc24 mutation and
randomize the budding pattern of wild-type cells. As Krev-1 overexpression can suppress ras-induced
transformation of mammalian cells, we looked for effects of RSR1 on the S. cerevisiae Ras pathway. Although
no suppression of the activated RAS2Va-l9 allele was observed, overexpression of rsrl Val-12 suppressed the
lethality of strains lacking RAS gene function, apparently through a direct activation of adenylyl cyclase. This
interaction of Rsrlp with the effector of Ras in S. cerevisiae suggests that Krev-1 may revert ras-induced
transformation of mammalian cells by affecting the interaction of ras p21 with its effector.
Ras proteins are important regulators of cell proliferation
and, when deregulated, can cause neoplastic transformation.
They bind and hydrolyze GTP, working as molecular
switches in transducing growth or differentiation signals (4,
19). The oncogenic transformation induced by activated
K-ras can be suppressed by overexpression of another
GTP-binding protein, the product of the Krev-1 gene (also
known as smg21A and rapJA), whose sequence is -53%
identical to that of the K-ras product (31, 33, 42). This
sequence similarity includes an exact conservation of the
putative effector domain (amino acids 32 to 42 [4, 24, 51]).
The mechanism by which Krev-1 suppresses ras-induced
transformation is unclear and could involve either direct
interference with the effector function(s) stimulated by ras
p21 or activation of an alternative pathway that leads to
growth inhibition. It has been reported that Krev-1 p21 binds
tightly to ras GTPase-activating protein (GAP) in vitro (18,
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24); although the GTPase activity of Krev-1 p21 is not
activated by ras GAP, Krev-1 p21 acts effectively as a
competitive inhibitor of the stimulation of ras GTPase activ-
ity by ras GAP (18). These observations suggest that Krev-1
antagonizes ras-induced transformation by sequestering ras
GAP or some other protein(s) that is needed for Ras func-
tion.
Because of the extent of functional conservation between
yeast and mammalian cells, Saccharomyces cerevisiae has
been an invaluable tool in the analysis of Ras function. In
this yeast, the RAS] and RAS2 gene products play a central
role in growth control and function, at least in part, by
stimulation of adenylyl cyclase (19, 60). The CDC25 and IRA
gene products are involved in the regulation of Raslp and
Ras2p activity. Cdc25p is a positive element that promotes
formation of the active Ras-GTP complex, probably by
acting as a nucleotide exchange factor (11, 16, 28, 34, 46).
Iralp and Ira2p are negative elements that promote the
formation of the Ras-GDP complex, probably by stimulating
ras GTPase activity (54, 56-58). The Ira proteins share
significant amino acid sequence similarity with mammalian
ras GAP in its catalytic domain, and ras GAP can comple-
ment the loss of IRA] and IRA2 (3, 57).
In the past few years, it has become clear that eukaryotic
cells contain a large number of Ras-related proteins, which
apparently serve a wide variety of roles in cell physiology (8,
9, 21). One recent addition to this Ras superfamily is the
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RSRJ AND Krev-1 GENES 759
TABLE 1. S. cerevisiae strains
Strain Genotype Source or reference
Y308 MATa ura3 leu2 Segregant from Y246 (5)
SY1229 MATa ura3 leu2 his3 6
Y301 MATo rsrl::URA3 ura3 leu2 his3 5
Y419 MATa rsrl::ura3 ura3 leu2 his3 Y301 rendered Ura- by growth on 5-
fluoroorotic acid
Y147 MATa cdc244 ura3 leu2 his3 5
TK161-R2V MATa RAS2Val-19 ura3 Ieu2 trpl his3 ade8 canl 60
T50-3A MATa cyrl-2 ura3 leu2 trpl his3 29
RS60-15B MATx RAS2Va-l9.Ala-22 ura3 Ieu2 trpl his3 ade2 Segregant from RS16-4C x STS13 (44)
ade8
KMY208-3C MATa cdc25-1 ura3 leu2 trpl ade2 Derived from strain 321 (23)
TT1A-1 MATot cdc25::URA3 ura3 leu2 trpi his3 ade8 11
[pCDC25(TRPI)-1]
KMY401-4D MATa iral::LEU2 RAS2Val-19.AIa-22 ura3 leu2 trpl Derived by several crosses from RS60-15B and
his3 ade2 ade8 KT7 (56)
KT62-2D MATas ira2::HIS3 ura3 Ieu2 trpl his3 K. Tanaka; derived from KT27 (58)
RRY8-5B MATot iral::LEU2 RAS2VaIl9.Ala-22 ura3 leu2 trpl Segregant from KMY401-4D x KT62-2D
his3 ade2
RRY8-14B MATa ira2: :HIS3 RAS2Val-19,Ala-22 ura3 Ieu2 trpl Segregant from KMY401-4D x KT62-2D
his3 ade2
RRY8-4A MATot iral::LEU2 ira2::HIS3 RAS2Val-l9.Ala-22 Segregant from KMY401-4D x KT62-2D
ura3 Ieu2 trpl his3 ade8
KMY45-2D MATa rasl::URA3 ura3 leu2 trpl his3 ade8 K. Matsumoto
KMY401-5A MATot RAS2Va-l9.Ala-22 ura3 Ieu2 trpl lys2 ade2 As for KMY401-4D
RRY5-29B MATa rasl::URA3 RAS2Val-19.Ala-22 ura3 leu2 trpl Segregant from KMY45-2D x KMY401-5A
his3 Iys2
KMY45-2A MATa rasl::HIS3 ura3 Ieu2 trpl his3 ade8 K. Matsumoto
KMY46-4Bp MATa ras2::URA3 ura3 Ieu2 trpl his3 ade8 Transformant of KMY46-4B (K. Matsumoto)
[YEp(rsrlval12)] with YEp(rsrlval12)
RRY9-19B MATa ura3 leu2 trpl his3 ade8 Segregant from KMY45-2A x KMY46-4Bp
RRY9-2D MATa rasl::HIS3 ras2:: URA3 ura3 Ieu2 trpl his3 Segregant from KMY45-2A x KMY46-4Bp
ade8 [YEp(rsrlval 12)]
RRY9-26A MATa rasl::HIS3 ras2:: URA3 ura3 leu2 trpl his3 Segregant from KMY45-2A x KMY46-4Bp
ade8 [YEp(rsrlvall2)]
product of the S. cerevisiae RSRJ gene, which was originally
identified as a multicopy suppressor of a temperature-sensi-
tive cdc24 mutation (5). The CDC24 product is involved in
the morphogenetic events of the S. cerevisiae cell division
cycle, including the selection of a nonrandom budding site
and the subsequent polarization of secretion and localization
of cell wall deposition to the bud (53). Deletion ofRSRJ itself
has no effect on growth rate but randomizes the selection of
budding sites, suggesting that Rsrlp may be necessary for
selection of the normal budding site but not for subsequent
events in the establishment of cell polarity and bud forma-
tion (5, 15). Among the miembers of the Ras superfamily,
Rsrlp is most similar to the mammalian Krev-1 gene prod-
uct, with which it shares 65% identity over the first 125
amino acids and 57% identity over the entire length (184
amino acids) of Krev-1 p21 (5), including a complete identity
with the putative effector-binding domains of both ras p21
and Krev-1 p21.
In this report, we explore further the role of RSR1 in
morphogenesis through the construction and analysis of
mutant alleles designed to be analogous to ras alleles that
result in constitutive activation or a dominant-negative ef-
fect. In addition, we characterize further the similarity of
Rsrlp to Krev-1 p21. In this respect, we show that the two
proteins share some functional homology and that overex-
pression of a mutant rsrl allele affects the yeast Ras-
mediated starvation response pathway by interacting with
adenylyl cyclase, the Ras effector in this organism.
MATERIALS AND METHODS
Strains, plasmids, and culture conditions. The S. cerevisiae
strains used in this study are described in Table 1, and the
plasmids used are described in Table 2. Yeast cells were
grown on standard rich (YPD or YM-P), defined minimal
(SD), defined complete (SC), or sporulation medium (35, 50)
at various temperatures as noted below. Selective media for
isolation of transformants and for determination of auxo-
trophic requirements were SC lacking the appropriate re-
quirement. SD+His medium was SD containing 25 ,ug of
histidine per ml; SD+His+Sorb medium was SD+His con-
taining 1 M sorbitol.
Recombinant DNA and genetic procedures. Except as
noted, standard procedures were used for recombinant DNA
manipulations, propagation of plasmids in Escherichia coli,
yeast transformations, and yeast genetics (26, 48, 50). To
create the rsrl Val-12 and rsrJAsn-l6 alleles, a 1.6-kb SacI-BglII
fragment containing all of RSRJ (5) was inserted into SacI-
BamHI-cut M13mpl9 (63) to create phage ABM5. Point
mutations were then created in ABM5 by using synthetic
oligonucleotides and the Bio-Rad (Richmond, Calif.) Muta-
Gene kit. The oligonucleotides used were 5'-G GGT GCT
GTT GGT GTC G-3', which should change RSRJ codon 12
(GGT, Gly) to GTT (Val), and 5'-GTC GGT AAT TCC TGC
TT-3', which should change RSRJ codon 16 (AAA, Lys) to
AAT (Asn). By using DNA sequencing (49), two indepen-
dent DNAs containing each of the mutations were identified.
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760 RUGGIERI ET AL.
TABLE 2. Plasmids
Plasmid Characteristics Source or reference
YCp5O URA3, ARSI, CEN4 (low copy number) 47
YEp13 LEU2, 2,um ARS' (high copy number) 10
pSL113 LEU2, 2,um ARS (rearrangement of YEp13; high copy number) 5
YEp24 URA3, 2Rm ARS (high copy number) 7
pKT10 URA3, 2,um ARS, TDH3 (glyceraldehyde-3-phosphate K. Tanaka (25, 38, 55)
dehydrogenase) promoter (high copy number)
pPB117 RSRJ in YEp24 Original isolate from
YEp24 library (5)
YCp(RSR1) RSRJ in YCp5O This study (see text)
YEp(RSR1) RSRI in pSL113 This study (see text)
YCp(rsr1vaIl2) rsrlval-12 in YCp5O This study (see text)
YEp(rsrlvaIl2) rsrlval-12 in pSL113 This study (see text)
pPB410 rsrJval-12 in YEp24 This study (see text)
YCp(rsrlasnl6) rsrJAsn-l6 in YCp5O This study (see text)
YEp(rsrlasnl6) rsrIAsn-l6 in pSL113 This study (see text)
pKTsmg21A EcoRI fragment containing bovine smg2JA cDNA (31) inserted at the This study
EcoRI site of pKT10 (and hence under control of the TDH3
promoter)
pKTCsmg2l As for pKTsmg21A, except that most smg2JA 3' noncoding This study
sequences (everything 3' to the BglII site [31]) have been deleted
YCpADH-RASl YCp5O containing RASI fused to the ADHI (alcohol dehydrogenase) 20, 37
promoter
YCpADH-RAS2 YCp5O containing RAS2 fused to the ADHI promoter 20, 37
YCpADH-RAS2[Ala-18, Val-19] YCp5O containing RAS2Ala-18VaIl9 fused to the ADHI promoter 37
AAH5-Ha-ras LEU2, 2,um ARS, wild-type human ras gene fused to the ADHI 17, 20, 37
promoter (high copy number)
AAH5-Ha[Val-12, Thr-59]-ras Like AAH5-HA-ras except mutant human ras gene 20, 37, 52
YEpRAS2-1 RAS2, LEU2, 2,um ARS (high copy number) 43
pRAS2val19 RAS2Val-l9, LEU2, 2 pum ARS (high copy number) 11
YEpRHOI RHO], URA3, 2,um ARS (high copy number) pWT of reference 36
pCDC25 (TRPI)-1 CDC25, TRPI, ARSI 11
YCpN1 TRPI, ARSI, CEN3 (low copy number) 41
YCpRAS2vaIL9 RAS2Val-19, URA3, TRPI, ARSI, CEN4 (low copy number) K. Tanaka
YEpTPKI TPKI, LEU2, 2Rm ARS (high copy number) 59
a ARS, autonomously replicating sequence.
The mutant alleles were then cloned into YCp50, pSL113,
and YEp24 by cutting the mutated ABM5 with BglII (0.55 kb
away -from the polylinker) and with SalI (in the polylinker)
and it, erting the resulting fragments into BamHI-SalI-cut
YCp50, pSL113, or YEp24. Plasmid YCp(RSR1) was con-
structed similarly, using YCp50 and nonmutagenized ABM5.
To construct plasmid YEp(RSR1), nonmutagenized ABM5
was cut with BglII and HindIII (in the polylinker), and the
resulting fragment was inserted into BamHI-HindIII-cut
pSL113.
Morphological observations. To visualize bud scars, cells
were stained with Calcofluor and observed by fluorescence
microscopy as described previously (45).
cAMP assay. Glucose-induced cyclic AMP (cAMP) forma-
tion was determined in stationary-phase cells as described
previously (40), using the cAMP determination kit (Amer-
sham, Arlington Heights, Ill.).
RESULTS
Functional characterization of rsrl mutants. Rsrlp appears
to be necessary for the normal selection of nonrandom
budding sites but not for subsequent essential events in
polarity establishment and bud formation (see the introduc-
tion). However, it is also possible that the nonlethality of the
rsrl deletion reflects functional redundancy of Rsrlp. To
investigate this possibility and to explore further the role of
Rsrlp in bud site selection, we used oligonucleotide-directed
mutagenesis to create two rsrl alleles that we thought might
have dominant-negative effects. In one mutant, glycine 12
was replaced by valine, producing a mutant Rsrlp analogous
to the constitutively activated products of the human
rasvaIl2 and S. cerevisiae RAS2Val-19 alleles (4, 30). In the
second mutant, lysine 16 was replaced by asparagine, pro-
ducing a mutant Rsrlp analogous to Ha-ras p2lAsn-16, a
protein that binds guanine nucleotides -100-fold less well
than does the wild type and has dominant-lethal effects when
expressed in yeast cells (52).
When either mutant allele was introduced into the rsrl
deletion strain Y419 (Table 1) on a low-copy-number plasmid
[YCp(rsrlval12) or YCp(rsrlasnl6); Table 2], the transfor-
mants grew well but still displayed the randomized budding
pattern characteristic of strains lacking Rsrlp (Fig. 1C and
data not shown). In contrast, Y419 cells harboring a similar
plasmid containing the wild-type RSRJ gene [YCp(RSR1)]
displayed the normal unipolar budding pattern of haploid
cells (Fig. 1A and B). When YCp(rsrlva1l2) or YCp(rsrlasnl6)
was introduced into the wild-type strain Y308, the transfor-
mants appeared to grow normally but displayed a random-
ized budding pattern (Fig. 1D and E); transformation of Y308
with YCp(RSR1) or YEp(RSR1) produced no such effect
(data not shown). Introduction of either mutant allele at high
copy number [strain Y301 transformed with plasmid
YEp(rsrlval12) or strain SY1229 transformed with plasmid
YEp(rsrlasnl6)] produced essentially the same phenotype:
the cells grew well at 12, 30, and 37°C, but the budding
pattern was randomized. These results indicate that neither
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FIG. 1. Budding patterns in cells of different genotypes. Cells
were grown at 23°C and observed by fluorescence microscopy after
staining with Calcofluor. (A) Wild-type strain Y308 harboring con-
trol plasmid pKT10; (B) rsrl deletion strain Y419 harboring plasmid
YCp(RSR1); (C) strain Y419 harboring plasmid YCp(rsrlval2); (D)
strain Y308 harboring plasmid YCp(rsrlvall2); (E) strain Y308 har-
boring plasmid YCp(rsrlasnl6); (F) strain Y308 harboring plasmid
pKTCsmg2l. Strains and plasmids are described in Tables 1 and 2.
rsrJVall2 nor rsrJAsn,l6 can supply Rsrlp function for normal
bud site selection; indeed, the mutant proteins interfere with
the function of the normal Rsrlp. Although this interference
is observed even at low copy numbers, there is no pro-
nounced effect on viability or growth rate even when the
mutant alleles are present at high copy numbers.
We also tested the ability of rsrlvall2 and rsrJAsn-l6 to
suppress a cdc24(Ts) mutation. When introduced into strain
Y147, plasmid YEp(rsrlvall2) or pPB410 produced effective
suppression (Fig. 2 and data not shown). In contrast,
YCp(rsr1val12), YCp(rsrlasnl6), and YEp(rsrlasnl6) all failed
to suppress effectively when introduced into the same strain
(data not shown). Indeed, rsrJAsnl16 interfered with the
suppression of cdc24 by RSRJ; that is, Y147 cells containing
both YEp(rsrlasnl6) and pPB117 failed to grow at 35°C even
in the presence of 1 M sorbitol (Fig. 2). In contrast, rsrJAsnl16
did not interfere with the suppression of cdc24 by rsrJVaIl2:
Y147 cells containing both YEp(rsrlasnl6) and pPB410 could
grow at 35°C (Fig. 2).
Functional homology of RSR1 and K-rev-1. To determine
whether the similarity in amino acid sequence between
Rsrlp and Krev-1 p21 is associated with functional homol-
ogy, we first examined whether expression of Krev-1 p21 in
yeast cells could suppress the randomized budding pattern of
the rsrl deletion strain. Transformation of strain Y419 with
plasmid pKTsmg2lA produced no detectable correction of
the abnormal budding pattern (data not shown), indicating
that Krev-1 p21 cannot supply normal Rsrlp function. How-
ever, introduction of pKTsmg2lA or the related plasmid
pKTCsmg2lA into the wild-type strain Y308 produced a
randomization of the budding pattern (Fig. 1F and data not
shown). This is not a general effect of overexpressing
FIG. 2. Suppression of temperature sensitivity in a cdc24 strain
by wild-type and mutant RSRJ. Strain Y147 was transformed with
pSL113 or with YEp(rsrlasnl6). Each of the two resulting strains was
transformed with pPB117 or with pPB410. For each of the four
resulting strains, two independent transformants were grown to
saturation in SD+His at 23°C, diluted 1:10 with SD, and spotted
onto duplicate SD+His+Sorb plates. One plate was incubated at
23°C for 3 days, while the other was incubated at 35°C for 2 days.
The plasmids present are (1) pPB117 and pSL113, (2) pPB410 and
pSL113, (3) pPB117 and YEp(rsrlasnl6) and (4) pPB410 and
YEp(rsrlasnl6). Plasmids are described in Table 2.
ras-like genes in yeast cells, as no such effect was seen when
Y308 was transformed with plasmid YCpADH-RASJ,
YCpADH-RAS2, or YCpADH-RAS2[Ala-18, Val-19], while
only a slight effect on budding pattern (occasional cells
showing apparent bipolar budding) was seen with plasmid
AAH5-Ha-ras. These results suggest that Krev-1 p21 can
interact with at least some of the proteins with which Rsrlp
normally interacts in the pathway that determines bud posi-
tion.
This conclusion was supported by the ability of Krev-1 to
suppress a cdc24(Ts) mutation. As in the case ofRSRJ itself,
the suppression was effective on YPD medium at 35°C (Fig.
3A) but not at 37°C (Fig. 3B). As with the effect on bud
position, this effect of Krev-1 was not a general property of
ras-like genes, as plasmids YCpADH-RASJ, YCpADH-
RAS2, YCpADH-RAS2[Ala-18, Val-19], YEpRAS2-1,
pRAS2VaIl9, AAH5-Ha-ras, AAH5-Ha[Val-12,Thr-59]-ras,
and YEpRHOI had little or no effect on the temperature
sensitivity of the cdc24 strain.
Suppression by RSRI of mutations that inactivate the yeast
Ras pathway. Overexpression of Krev-1 can suppress trans-
A B
I
2
3
4
FIG. 3. Suppression of temperature sensitivity in a cdc24 strain
by Krev-1. Strain Y147 was transformed with various plasmids, and
cells were patched onto YPD medium in duplicate and grown for 3
days at 35°C (A) or 37°C (B). Plasmids tested were (1) YEp24, (2)
pPB117, (3) pKT10, and (4) pKTsmg2lA. Plasmids are described in
Table 2.
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FIG. 4. Suppression of mutations of the Ras pathway by RSR1
and rsrlva l2. Strains T50-3A [cyrl(Ts); row 1], RS60-15B
[RAS2(Ts); row 2], and KMY208-3C [cdc25(Ts); row 3] were
transformed with plasmids YEp13 (A), YEp(RSR1) (B), and
YEp(rsrlvaIl2) (C) and tested for growth at 35°C as described in the
legend to Fig. 3. Strain T50-3A was transformed only with plasmid
YEp(rsrlval12).
formation caused by activated ras alleles in mammalian
cells. As RSRJ seems to have at least some functional
homology to Krev-1, we tested whether overexpression of
RSRJ could suppress the phenotypes caused by the acti-
vated RAS2Va-l9 allele, such as sensitivity to heat shock and
nitrogen starvation, failure to arrest in the G1 phase of the
cell cycle, and failure to sporulate (30, 60). However, neither
plasmid YEp(RSR1) nor plasmid YEp(rsrlvall2) was able to
suppress the phenotypes due to RAS2Va l9 when introduced
into strain TK161-R2V (data not shown). On the other hand,
overexpression of RSRJ did suppress a cdc25(Ts) mutation,
which causes a defect in the activation of Ras at high
temperatures (Fig. 4A and B, row 3). To test whether RSRJ
could suppress a complete loss of CDC25 function, we
introduced plasmid YEp(RSR1) into cdc25:: URA3 cells that
carried the wild-type CDC25 gene on a TRPI-containing
plasmid (strain TT1A-1; Table 1). We then examined
whether the RSRI plasmid could confer viability to these
cells in the absence of the CDC25 plasmid. However, when
growth in rich medium was followed by replica plating to
selective media, no Leu+ Trp- colonies were observed,
indicating that overexpression of RSRI could not suppress a
deletion of CDC25. Overexpression of RSRJ also failed to
suppress a RAS2(Ts) allele (Fig. 4B, row 2), which is a
dominant-negative allele believed to sequester Cdc25p while
being unable to activate adenylyl cyclase at the restrictive
temperature (44). However, overexpression of the rsrlVall2
allele caused a stronger effect: plasmid YEp(rsrlvaIl2) could
suppress the growth defects not only of the cdc25(Ts)
mutation (Fig. 4C, row 3) but also of the cdc25 deletion
mutation (data not shown) and of the RAS2(Ts) mutation
(Fig. 4C, row 2). However, YEp(rsrlvaIl2) could not sup-
press the adenylyl cyclase-defective cyrl(Ts) mutation (Fig.
4C, row 1), suggesting that the effect of Rsrlp on the Ras
pathway is at or upstream of the activation of this enzyme.
One possible explanation for the suppression of Ras
pathway mutations by RSRJ and rsrJVail2 is that Rsrlp may
bind to and sequester the Ira proteins, thus allowing the Ras
proteins to accumulate in their active GTP-bound state and
bypassing the requirement for Cdc25p (Fig. 5A). In accord
with this model, we found that the growth defect of the
RAS2(Ts) mutant, like that of a cdc25 mutant (56), could be
suppressed by disruption of both IRA genes (Table 3).
Another possibility is that Rsrlp may directly activate ade-
nylyl cyclase in the place of the Ras proteins (Fig. SB). In
A S cdc25 so
0-------------
cAMP
GDP GTP
(SRI a12
B ;t'''''Is
'cdc25 ,
(3-------'---w cAMP
GDP GTP
FIG. 5. Models for suppression of a cdc25 defect by rsrJiaIl2.
Solid boxes and arrows indicate active proteins and processes;
hatched boxes and arrows indicate defective proteins and processes.
See text for additional explanation. Similar models could be consid-
ered for the suppression of RAS2(Ts) by rsrl Va[l2; suppression
through interaction with the Ira proteins (A) would be mediated by
Raslp.
accord with this model, the growth defect of rasi RAS2(Ts)
cells was also suppressed by the rsrJVaIl2 plasmid (Table 3).
To investigate the second model further, we tested
whether rsrlVal-12 could suppress the lethality caused by a
complete lack of both RAS genes; such suppression would
be expected only under the second model (Fig. 5). A rasi
strain (KMY45-2A) was crossed to a ras2 strain carrying
rsrlvaIl2 on a high-copy-number plasmid (KMY46-4Bp),
and the haploid progeny obtained by tetrad analysis were
analyzed for the genetic markers corresponding to the ras
mutations and to the plasmid. Table 4 shows that the
segregants predicted by meiotic recombination were ob-
tained and that, as expected, spores carrying both ras
mutations were mostly nonviable. The only viable rasi ras2
segregants observed carried the rsrJVaIl2 plasmid. To con-
firm that growth was indeed dependent on the rsrJVaIl2
plasmid, we transformed these segregants either with the
TRPJ-containing control plasmid YCpN1 or with the TRPI-
containing plasmid YCpRAS2Val19 and tested the ability of
TABLE 3. Suppression of RAS2(Ts) by ira mutations or by
rsrlVal-12 overexpressiona
Strain Relevant genotype Growth at 37°C
RRY8-5B iral RAS2(Ts)
RRY8-14B ira2 RAS2(Ts)
RRY8-4A iral ira2 RAS2(Ts) +
RRY5-29B rasi RAS2(Ts) +
[YEp(rsrlvall2)]
The strains used are described in Table 1. Suppression of the RAS2(Ts)
temperature-sensitive growth phenotype was tested by streaking cells on both
rich and selective media and incubating them for 3 days at 37C.
MOL. CELL. BIOL.
 o
n
 February 26, 2014 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
RSRJ AND Krev-1 GENES 763
TABLE 4. Rescue of rasi ras2 mutants by YEp(rsrlvall2)a
No. of spores
Genotype
Viable Nonviable
RASI RAS2 8 0
rasl RAS2 22 0
RAS] ras2 22 0
rasl ras2 0 5
rasl ras2 [YEp(rsrlvall2] 3 0
a Strains KMY45-2A and KMY46-4Bp (Table 1) were crossed, and 15
tetrads containing three or four viable spores were analyzed. The genotypes of
viable spores were assigned by scoring the selectable markers associated with
the gene disruptions or with the plasmid; the genotypes of nonviable spores
with inferred from the genotypes of their sister segregants. The presence or
absence of plasmid is indicated only for the rasl ras2 segregants.
the transformants to segregate the plasmids upon growth in
rich medium. With the transformants carrying the control
plasmid in addition to the rsrJVaIl2 plasmid, we found no
Leu- segregants although Trp- segregants were obtained in
the expected frequency (Table 5). In contrast, when the
RAS2Va-l9 plasmid was present in addition to the rsrlVaIl12
plasmid, Leu- as well as Trp- segregants were observed
(Table 5). However, no Leu- Trp- clones were obtained.
Thus, the cells could segregate either the rsrJVaIl2 plasmid
or the RAS2VaIl9 plasmid, but not both, indicating that the
viability of rasi ras2 cells was indeed supported by the
rsrJval-12 plasmid.
A similar experiment showed that wild-type RSRJ did not
suffice for suppression of the rasi ras2 double mutation.
When RRY9-2D in which YCpRAS2va,l9 had been substi-
tuted for YEp(rsrlval12) (see above and Table 5) was trans-
formed with YEp(RSR1) and grown on rich medium, Leu-
segregants but no Trp- segregants were observed (data not
shown).
Stimulation of adenylyl cyclase by rsrlvaIl2. To confirm
that rsrJVaIl2 has a direct effect on the adenylyl cyclase
complex, we tested the ability of the rasi ras2 cells carrying
the rsrJVaIl2 plasmid to produce cAMP. In two steps of
plasmid swapping like that of Table 5, the rsrJVal-12 plasmid
of strain RRY9-2D was replaced first by YCpRAS2VaIl9 and
then by YEpTPKI, which carries gene TPKJ (encoding one
isoform of the catalytic subunit of cAMP-dependent protein
kinase). Overexpression of TPKI is known to support
growth of cells lacking both RAS genes by activating events
downstream of the cAMP formation step (13, 59). As re-
ported previously (56), cAMP was not detectable in such
downstream-activated cells (Fig. 6B). In contrast, rsrlVW-l2
conferred on these cells the ability to produce cAMP to
levels about half those of wild-type cells (Fig. 6). Thus,
rsrJVaIl2 can support the growth of rasi ras2 cells by
directly stimulating the adenylyl cyclase complex and
thereby bypassing the normal requirement for the Ras pro-
teins.
DISCUSSION
Roles of Rsrlp and related proteins in cellular morphogen-
esis. Analysis of the rsrJVal-12 and rsrJAsnl16 mutants has
provided some significant insights into the normal roles of
Rsrlp and functionally related proteins. First, the observa-
tion that a wild-type strain harboring a low-copy-number
rsrJAsn-l6 plasmid shows the same phenotype (random bud-
ding pattern) as an rsrl deletion strain indicates that the
rsrJAsn16 allele encodes a dominant interfering protein, as
TABLE 5. Dependence of rasl ras2 mutants on either rsrlvaIl2
or RAS2VaIl9 for viabilitya
Proportion of colonies
Strain Additional that were:plasmid
Leu- Trp-
RRY9-2D YCpNl 0/300 60/300
YCpRA.S2val19 76/370 54/370
RRY9-26A YCpNl 0/400 80/400
YCpRAS2val9 146/277 13/277
"Two rasi ras2 [YEp(rsrlvaIl2)] segregants from the cross of KMY45-2A to
KMY46-4Bp (Tables 1 and 4) were transformed with the additional plasmids
indicated (Table 2), grown for several generations in YPD medium at 25'C,
and tested by replica plating for the loss of YEp(rsrlvatl2) (Leu- colonies) or
of the additional plasmid (Trp- colonies).
expected. More important, the viability of this strain, and
even of a strain harboring rsrJAsnl16 on a high-copy-number
plasmid, suggests that the nonlethality of the rsrl deletion
cannot be explained simply by functional redundancy of
RSRJ; if this were the case, the dominant interfering protein
would presumably be lethal. In other words, RSRJ appears
to function only in bud site selection, not in the subsequent
essential steps of polarity establishment and bud formation.
This role contrasts with those of CDC24 and CDC42. Muta-
tion (CDC24) or overexpression (CDC42) of these genes can
also randomize bud position (27, 53), but a loss of either gene
product leads to a lethal inability to establish cell polarity (1,
23, 27, 53). One attractive model is that Rsrlp is one of a set
of proteins (14, 15) that communicates the positional infor-
mation for normal bud site selection to a second set of
proteins that includes Cdc24p and Cdc42p; these latter
proteins would then direct the formation of the polarized
cytoskeletal assemblies necessary for bud formation. In the
absence of the normal positional information, the Cdc24p/
Cdc42p set of proteins would simply direct cytoskeletal
assembly to a random site on the cell surface.
Second, the observation that an rsrJvaIl2 plasmid does
not correct the random budding pattern of an rsrl deletion
strain suggests that the normal function of Rsrlp depends on
a cycling between GTP-bound and GDP-bound states and
not simply-on having a sufficient fraction of the protein in an
active (GTP-bound) conformation. The observation that
rsrJva l2 plasmids can interfere with bud site selection even
in a wild-type strain further supports this view. In this
respect, Rsrlp appears to resemble GTP-binding proteins
involved in vectorial processes (8, 9), such as Sec4p and
Yptlp, more than it does Ras proteins. One plausible model
is that the switch from the GDP-bound to the GTP-bound
form might signal the successful completion of one stage
(and/or readiness for the next stage) in the assembly of a
prebudding protein complex at the prospective budding site.
Finally, the observation that a high-copy-number
rsrlVaIl2 plasmid suppresses the lethal cdc24 mutation sheds
some light on the relationship between Rsrlp and Cdc24p.
As RsrlpvaIl2 appears not to have normal Rsrlp function
(see above), it does not appear that this suppression can be
explained by the hypothesis that a constitutive activation of
Rsrlp bypasses the need for Cdc24p function (as might be
the case if Rsrlp functioned downstream of, or was activated
by, Cdc24p). This conclusion is supported by the observa-
tion that high-copy-number rsrlvaIl2 actually suppresses
less well than does high-copy-number RSRJ (data not
shown). A plausible alternative hypothesis is that the sup-
pression of cdc24 results from the increased amount of Rsrlp
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FIG. 6. Restoration of cAMP levels in rasi ras2 double mutants by rsrlvall2. Cells of strain RRY9-2D (Table 1) were grown to stationary
phase in YPD liquid medium at 25°C. One aliquot of this culture was then plated on YPD medium; when colonies appeared, they were replica
plated onto selective media to confirm the dependency of growth on the rsrJVaIl2 plasmid. A second aliquot of the same culture was washed
twice with water and then incubated for 2 h at 25°C in a buffer containing 10 mM morpholine ethanesulfonic acid (pH 6.5) and 0.1 mM EDTA.
Glucose was then added to a final concentration of 25 mM, and after various periods of time 0.5-ml aliquots were transferred to 0.5 ml of 10%
(wt/vol) trichloroacetic acid. The cAMP contents were then measured as described in Materials and Methods. The data shown (B; El) are from
a single analysis but are representative of results obtained in repeated experiments with RRY9-2D as well as with strain RRY9-26A (Table
1). Similar experiments were performed with the congenic wild-type strain RRY9-19B (Table 1) (A) and with a derivative ofRRY9-2D in which
the rsrvl 2 plasmid had been replaced by the TPKI-containing plasmid YEpTPKI (see text and Table 2) (B; A).
(either wild type or the Vall2 form) stabilizing an enfeebled
Cdc24p by direct protein-protein interaction. This hypothe-
sis is consistent with the observation that suppression of
cdc24 by either RSRJ or rsrJVaIl2 is dosage dependent:
low-copy-number RSRJ plasmids suppress less well than do
high-copy-number RSRJ plasmids (4a, 5), and low-copy-
number rsrJVaIl2 plasmids suppress little or not at all (see
Results). Such an interaction between Rsrlp and Cdc24p
could, of course, be a component of the mechanism for
communicating positional information, as suggested above.
Perhaps it is the complex of Cdc24p and the GTP-bound
form of Rsrlp (as presumably represented by Rsrlpval12)
that normally participates in the next stage in the assembly
of the prebudding complex; with wild-type Rsrlp, the
Cdc24p-Rsrlp[GTP] complex would form only at the proper
site. In this regard, it is also of interest that rsrJAsnl6 cannot
suppress the cdc24 mutation. It seems likely that RsrlpAsn-l6
is unable to interact with Cdc24p (thus explaining its inability
to suppress) but can still compete with Rsrlp for binding to
other elements of the position-signalling apparatus (thus
explaining its dominant effect on budding pattern). The
ability of rsrJAsnl16 to interfere with the suppression of cdc24
by RSRJ could be explained if this competition prevents
Rsrlp from being switched to the GTP-bound form and if
only Rsrlp[GTP] is competent to interact with Cdc24p. The
observation that rsrJAsnl6 cannot interfere with the suppres-
sion of cdc24 by rsrJVaIl2 is consistent with this interpreta-
tion.
Functional homology between Rsrlp and Krev-1 p21. Two
lines of evidence suggest that the structural similarity be-
tween Rsrlp and Krev-1 p21 is reflected in a functional
homology. First, expression of Krev-1 in yeast cells can
randomize the budding pattern of wild-type cells, presum-
ably by interacting with one or more normal components of
the machinery for bud site selection and thus interfering with
this process. Second, expression of Krev-1 p21 can suppress
a cdc24 mutation. Although overexpression of the GTP-
binding protein Cdc42p can also both randomize bud posi-
tion (27) and suppress a cdc24 mutation (5), such effects are
not generic consequences of overexpressing Ras-like pro-
teins in yeast cells, as no similar effects were observed with
plasmids containing a variety of other ras-like genes (see
Results).
The two effects noted for Krev-1 expression in yeast cells
might actually have a common basis; that is, binding of
Krev-1 p21 to Cdc24p (stabilizing the mutant Cdc24p and
potentiating subsequent steps in the assembly of the pre-
budding complex) might occur without reference to the
positional signals that would normally be necessary (perhaps
by promoting the exchange of GTP for GDP) for the binding
of Rsrlp to Cdc24p. Such an effect would be enhanced if
Krev-1 p21 were not subject to control by the (putative)
Rsrlp GAP. This would cause the mammalian protein to
accumulate in its GTP-bound state and thus behave more
like RsrlpvaIl2 than like wild-type Rsrlp. Such a lack of
control would be similar to the inability of yeast Ras GAP
(the products of the IRA genes) to affect the intrinsic GTPase
activity of mammalian Ha-ras p21 (54, 57). Regardless of the
detailed interpretation, the observations cited do appear to
indicate a functional homology between Rsrlp and Krev-1
p21.
Mechanism of Krev-1 reversal of ras-induced transforma-
tion. Given the apparent functional homology between Rsrlp
and Krev-1 p21, we examined whether Rsrlp could interact
with the Ras pathway in S. cerevisiae. Although no suppres-
sion of the activated RAS2VaIl9 allele was observed, over-
expression of rsrlVal-12 could suppress various mutations
that inactivate the Ras pathway. The observation that
rsrJVal-12 was more effective in this suppression than was
RSRJ parallels the observation that in mammalian cells, the
tumor suppression activity of Krev-1 is potentiated by sub-
stitution of Val for Gly at position 12 (32), a modification
analogous to that in RsrlpvalIl2. The cyrl(Ts) defect was not
suppressed by rsrJvaIl2, indicating that the suppression
involved a direct effect on the Ras pathway rather than an
activation of an independent growth-stimulating pathway.
Indeed, the stimulation ofcAMP formation in the absence of
the Ras proteins showed that Rsrlp can directly activate the
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adenylyl cyclase complex. In addition, the suppression of
the RAS2(Ts) mutation by elimination of both Ira proteins
raises the possibility that Rsrlp might also affect the Ras
pathway by interacting with and blocking the action of the
Ira proteins. Such an interaction would not be surprising
given the exact conservation between Rsrlp and the Ras
proteins of the "effector domain", which is believed to be
the site of interaction between ras p21 and ras GAP in
mammalian cells (2, 12). However, as yet we have no
experimental evidence that bears on this possibility.
The ability of RsrlpVaIl2 to stimulate adenylyl cyclase,
the Ras effector in S. cerevisiae, suggests that Krev-1 may
suppress ras-induced transformation in mammalian cells by
competing with ras p21 for an effector. This effector might or
might not be ras GAP (22, 39, 61), which has been reported
to bind tightly to Krev-1 p21 in vitro (18, 24). It is interesting
that Krev-1 can suppress the effects of ras activation in
mammalian cells, whereas in yeast cells it is a loss of Ras
pathway function that is suppressed by RSRJ (or rsrJVail2).
This difference appears similar to that observed in a recent
study of the expression of Krev-1 in S. cerevisiae and
Schizosaccharomyces pombe (62). In S. cerevisiae, Krev-1
was observed to interfere with RAS2 function, whereas in S.
pombe, Krev-1 p21 could stimulate some of the Ras effec-
tors. Taken together, these results suggest that a variety of
cross-pathway effects involving closely related members of
the Ras family are possible. However, the precise direction
of these effects is difficult to predict in individual cases. In
particular, the interaction with Ras effectors may sometimes
be stimulatory and sometimes inhibitory. Presumably, de-
tailed comparative studies of the effector-binding domains of
the various proteins will eventually rationalize these differ-
ences.
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